Literature DB >> 21508419

Can antiviral therapy of chronic hepatitis B prevent the development of hepatocellular carcinoma?

Mark Thursz1, Ashley Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21508419     DOI： 10.1136/gut.2010.236521

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  2 in total

Review 1.  Antiviral treatment to prevent chronic hepatitis B or C-related hepatocellular carcinoma.

Authors:  Li-Ping Chen; Jun Zhao; Yan Du; Yi-Fang Han; Tong Su; Hong-Wei Zhang; Guang-Wen Cao
Journal:  World J Virol       Date:  2012-12-12

2.  Intermediate-stage hepatocellular carcinoma patients with a high HBV-DNA load may benefit from postoperative anti-hepatitis B virus therapy.

Authors:  Shaozhen Rui; Jun Yan; Hui Zhang; Zhengfeng Wang; Wence Zhou
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.